Detailed contents
Part 1 Thyroid
1 Anatomy and physiology of the thyroid

2

Anatomy 2
Physiology 4
2 Thyroid investigations

7

Tests of hormone concentration 7
Tests of homeostatic control 7
Antibody screen 10
Scintiscanning 11
Ultrasound (US) scanning 13
Fine needle aspiration (FNAC) cytology 14
Computed tomography (CT) 14
Additional laboratory investigations 15
Sick euthyroid syndrome (non-thyroidal illness syndrome) 15
Atypical clinical situations 16
3 Thyrotoxicosis

17

Etiology 17
Manifestations of hyperthyroidism 19
Treatment 21
Thyroid crisis (storm) 28
Thyrotoxicosis in pregnancy 31
Hyperthyroidism in children 35
Secondary hyperthyroidism 36
4 Graves’ ophthalmopathy, dermopathy, and acropachy

39

Graves’ ophthalmopathy 39
Graves’ dermopathy 43
Thyroid acropachy 43
5 Multinodular goiter and solitary adenomas
Background 44
Clinical evaluation 45
Studies 46
Treatment 47
Pathology 48
Thyroid nodules in pregnant mothers 48

44

x

DETAILED CONTENTS

6 Thyroiditis

49

Background 49
Chronic autoimmune thyroiditis 50
Other types of thyroiditis 51
7 Hypothyroidism

53

Background 53
Clinical picture 55
Treatment of hypothyroidism 56
Treatment of subclinical hypothyroidism 57
Management of myxedema coma 58
Congenital hypothyroidism 60
8 Amiodarone and thyroid function

62

Background 62
Pathogenesis 63
Diagnosis and treatment 64
9 Thyroid cancer

66

Epidemiology 66
Etiology 67
Papillary thyroid carcinoma 68
Staging of DTC 69
Surgery 70
Postoperative thyroid hormone therapy 70
Radioactive iodine therapy 71
Management of recurrent disease 74
Follicular thyroid carcinoma (FTC) 75
Follow-up of papillary and follicular thyroid carcinoma 76
Medullary thyroid carcinoma (MTC) 78
Anaplastic (undifferentiated) thyroid cancer 79
Lymphoma 79

Part 2 Pituitary
10 Pituitary gland anatomy and physiology

82

Embryology and anatomy 82
Anterior gland physiology 83
Posterior gland physiology 85
11 Imaging
Background 86
MRI appearances 86
Pituitary adenomas 87
Craniopharyngiomas/Rathke’s cleft cyst 88

86

DETAILED CONTENTS

12 Pituitary function testing

89

Background 89
Lactotropes 89
Thyrotropes 89
Gonadotropes 90
Corticotropes 91
Somatotropes 93
13 Hypopituitarism

94

Deﬁnition 94
Etiologies of hypopituitarism 94
Features 95
Investigations 97
Treatment 97
14 Anterior pituitary hormone replacement

98

Background 98
Glucocorticoids replacement 98
Growth hormone replacement 99
Thyroid hormone replacement 100
Sex hormone replacement 100
15 Pituitary tumor basics

101

Epidemiology 101
Classiﬁcation 101
Pathophysiology 102
Investigations 102
Management and natural history 103
16 Prolactinomas

104

Epidemiology 104
Etiology and pathogenesis 104
Clinical features 104
Investigations 106
Hyperprolactinemia and drugs 106
Idiopathic hyperprolactinemia 106
Treatment 107
Management of prolactinomas in pregnancy 109
17 Acromegaly
Deﬁnition 110
Epidemiology 110
Etiologies of acromegaly 110
Pathophysiology 110
Clinical features 110
Investigations 112
Management 114
Mortality data 115

110

xi

xii

DETAILED CONTENTS

18 Cushing’s disease

116

Deﬁnition 116
Epidemiology 116
Differential diagnosis 116
Etiologies of CS 116
Clinical features of CS 117
Investigations 118
Treatment 122
Follow-up 124
19 Gonadotropinomas

125

Epidemiology 125
Pathology 125
Clinical features 125
Investigations 126
Management 126
Follow-up and prognosis 126
20 Thyrotropinomas

128

Epidemiology 128
Clinical features 128
Investigations 128
Management 128
21 Craniopharyngiomas and Rathke’s cleft cysts

130

Craniopharyngiomas 130
Epidemiology 130
Pathology 130
Clinical features 130
Investigations 131
Management 131
Follow-up 131
Rathke’s cleft cysts (RCC) 132
Epidemiology 132
Pathology 132
Clinical features 132
Investigations 132
Management 132
Follow-up 133
22 Parasellar tumors
Meningiomas 134
Germ cell tumor (GCT) 134
Gangliocytomas 134
Chordomas/condrosarcomas 135
Hamartomas 135
Metastatic tumors to the pituitary 135

134

DETAILED CONTENTS

23 Inﬂammatory and inﬁltrative pituitary diseases

136

Background 136
Investigations 137
Lymphocytic hypophysitis 137
Sarcoidosis 138
Langerhans’ cell histiocytosis 139
Hemochromatosis 139
24 Surgical treatment of pituitary tumours

140

Transsphenoidal surgery (TSS) 140
Transfrontal craniotomy 143
25 Medical treatment of pituitary tumors

144

Dopamine agonists (DA) 144
Somatostatin analogs 145
Growth hormone receptor antagonists 146
26 Pituitary radiotherapy

147

Background 147
Techniques 147
Efﬁcacy 148
Complications 149
27 Diabetes insipidus (DI)

151

Deﬁnition 151
Classiﬁcation and etiologies 151
Features 152
Investigations 153
Treatment 154
Caveats for water deprivation study 155
28 Hyponatremia

156

Incidence 156
Etiologies 156
Neurosurgical hyponatremia 157
Classiﬁcation and clinical features 157
Investigations 158
Hyponatremia treatment 158
29 Syndrome of inappropriate ADH (SIADH)
Deﬁnition 159
Features 159
Criteria for diagnosis 159
Types of SIADH 159
Treatment 160

159

xiii

xiv

DETAILED CONTENTS

30 Pineal gland

161

Physiology 161
Pineal and intracranial germ cell tumors 161
Features 161
Investigations and staging 161
Management 162
Prognosis 162

Part 3 Adrenals
31 Anatomy and physiology

164

Anatomy 164
Physiology 166
32 Imaging

168

Computed tomography (CT) scanning 168
Magnetic resonance imaging (MRI) 168
Ultrasound (US) imaging 168
Normal adrenal 169
Radionucleotide imaging 169
Positron emission tomography (PET) 169
Venous sampling 169
33 Mineralocorticoid excess

170

Deﬁnitions 170
34 Primary aldosteronism

171

Epidemiology 171
Pathophysiology 171
Clinical features 171
Conn’s syndrome—aldosterone-producing adenoma 171
Bilateral adrenal hyperplasia (bilateral idiopathic
hyperaldosteronism) 173
Glucocorticoid-remedial aldosteronism (GRA) 173
Aldosterone-producing carcinoma 173
Screening 174
Conﬁrmation of diagnosis 176
Localization and conﬁrmation of differential diagnosis 179
Treatment 180
35 Excess other mineralocorticoids
Epidemiology 182
Apparent mineralocorticoid excess 182
Licorice ingestion 183
Ectopic ACTH syndrome 183
Deoxycorticosterone (DOC) excess 183

182

DETAILED CONTENTS

36 Adrenal Cushing’s syndrome

184

Deﬁnition and epidemiology 184
Pathophysiology 184
Clinical features 185
Investigations 185
Treatment 186
Prognosis 186
Subclinical Cushing’s syndrome 187
37 Adrenal surgery

188

Adrenalectomy 188
38 Renal tubular abnormalities

190

Background 190
Liddle’s syndrome 190
Bartter’s syndrome 191
39 Mineralocorticoid deﬁciency

192

Epidemiology 192
Causes 192
Treatment 192
40 Adrenal insufﬁciency

193

Deﬁnition 193
Epidemiology 194
Pathophysiology 195
41 Addison’s disease

196

Causes of primary adrenal insufﬁciency 196
Autoimmune adrenalitis 197
Clinical features 198
Autoimmune polyglandular syndrome (APS) type 1 198
APS types 2–4 199
Investigation of primary adrenal insufﬁciency 200
Treatment 203
42 Long-term glucocorticoid administration

206

Short-term steroids 206
Steroid cover 206
Long-term steroids 207
Cushing’s syndrome 207
43 Adrenal incidentalomas
Deﬁnition and epidemiology 208
Importance 208

208

xv

xvi

DETAILED CONTENTS

Differential diagnosis of an incidentally detected adrenal
nodule 208
Investigations 209
Management 209
44 Pheochromocytomas and paragangliomas

210

Deﬁnition 210
Incidence 210
Epidemiology 210
Pathophysiology 212
Clinical features 213
Complications 213
Investigations 214
Management 218

Part 4 Reproductive endocrinology
45 Hirsutism

222

Deﬁnition 222
Physiology of hair growth 222
Androgen production in women 223
Evaluation 224
46 Polycystic ovary syndrome (PCOS)

227

Deﬁnition 227
Epidemiology 227
Other causes of hyperandrogenic anovulation 228
Features 230
Laboratory evaluation 232
Management 234
47 Congenital adrenal hyperplasia (CAH) in adults

239

Deﬁnition 239
Epidemiology 239
Pathogenesis 239
Biochemistry 240
Clinical presentation 241
Laboratory evaluation 242
Management 244
Monitoring of treatment 246
Prognosis 247
48 Androgen-secreting tumors
Deﬁnition 249
Epidemiology and pathology 249
Clinical features 250

249

DETAILED CONTENTS

Laboratory evaluation 250
Management 251
Prognosis 251
49 Menstrual function disorders

252

Deﬁnitions 252
Clinical evaluation 253
Laboratory evaluation 255
Management 256
50 Premature ovarian insufﬁciency (POI)

257

Deﬁnition 257
Epidemiology 257
Pathogenesis 259
Clinical presentation 260
Laboratory evaluation 261
Management 262
Prognosis 263
51 Menopause

264

Deﬁnition 264
Long-term consequences 266
Clinical presentation 266
Evaluation (if HRT is being considered) 267
Hormone replacement therapy (HT) 268
52 Oral contraceptive pill (OCP)

275

Introduction 275
Beneﬁts 276
Risks 277
Practical issues 279
53 Testicular physiology

280

Anatomy 280
Regulation of testicular function 281
Physiology 283
54 Male hypogonadism
Deﬁnition 284
Epidemiology 284
Secondary hypogonadism
(hypogonadotropic hypogonadism) 285
Primary hypogonadism
(hypergonadotropic hypogonadism) 289
Clinical assessment 293

284

xvii

xviii

DETAILED CONTENTS

55 Androgen therapy

296

Treatment goals 296
Indications for treatment 297
Risks and side effects 298
56 Gynecomastia

301

Deﬁnition 301
Evaluation 303
Management 305
57 Erectile dysfunction

306

Deﬁnition 306
Physiology of male sexual function 306
Pathophysiology 307
Evaluation 308
Management 311
58 Testicular tumors

314

Epidemiology 314
Risk factors 314
Prognosis 315
59 Infertility

316

Deﬁnition 316
Causes 317
Evaluation 319
Management 324
Ovulation induction 328
60 Disorders of sexual differentiation

332

Clinical presentation 332
Evaluation 333
Androgen insensitivity syndrome 335
True hermaphroditism 336
General principles of management 337
61 Transsexualism

339

Deﬁnition 339
Epidemiology 339
Etiology 339
Management 340

Part 5 Endocrine disorders of pregnancy
62 Thyroid disorders
Normal physiology 346
Maternal hyperthyroidism 347

346

DETAILED CONTENTS

Maternal hypothyroidism 349
Postpartum thyroid dysfunction 350
Thyroid cancer in pregnancy 351
63 Pituitary disorders

352

Normal anatomical changes during pregnancy 352
Normal physiology during pregnancy 353
Prolactinoma in pregnancy 354
Cushing’s syndrome 356
Acromegaly 357
Hypopituitarism in pregnancy 358
64 Adrenal disorders during pregnancy

361

Normal changes during pregnancy 361
Addison’s disease in pregnancy 362
Congenital adrenal hyperplasia 363
Pheochromocytoma 364

Part 6 Calcium and bone metabolism
65 Calcium and bone physiology

366

Bone turnover 366
Bone mass during life 367
Calcium 368
66 Investigation of bone

369

Bone turnover markers 369
Bone imaging 370
Bone mass measurements 371
Bone biopsy 372
67 Investigation of calcium, phosphate, and magnesium

373

Blood concentration 373
Urine excretion 374
Calcium-regulating hormones 375
68 Hypercalcemia
Epidemiology 376
Causes 376
Clinical features 377
Hyperparathyroidism 379
Treatment 382
Complications of parathyroidectomy 384
Other causes of hypercalcemia 385
Familial hypocalciuric hypercalcemia (FHH) 387
Vitamin D intoxication 387
Sarcoidosis 388

376

xix

xx

DETAILED CONTENTS

69 Hypocalcemia

389

Causes 389
Clinical features 391
Investigation 393
Treatment 394
70 Rickets and osteomalacia

396

Deﬁnitions 396
Clinical features 396
Diagnosis 397
Vitamin D deﬁciency 399
Hypophosphatemia 401
71 Hypomagnesemia

403

Introduction 403
Treatment 404
72 Osteoporosis

405

Introduction 405
Pathology 406
Epidemiology 408
Presentation 409
Investigation 410
Treatment 413
Complications of therapy 417
73 Paget’s disease

421

Pathology 421
Epidemiology 422
Clinical features 422
Investigation 423
Complications 424
Treatment 425
Monitoring therapy 426
74 Inherited disorders of bone

427

Osteogenesis imperfecta 427

Part 7 Pediatric endocrinology
75 Growth and stature
Growth 430
Short stature 434
Genetic short stature 436
Constitutional delay of growth and puberty 436
Growth hormone deﬁciency 437
Tall stature and rapid growth 445

430

DETAILED CONTENTS

76 Puberty

447

Normal puberty 447
Precocious puberty 449
Delayed or absent puberty 453
77 Sexual differentiation

455

Normal sexual differentiation 455
Assessment of ambiguous genitalia 456
Disorders of sex development (DSD) 457
Congenital adrenal hyperplasia 459

Part 8 Neuroendocrine disorders
78 The neuroendocrine system

464

Introduction 464
79 Carcinoid tumors

465

Deﬁnition and classiﬁcation 465
Incidence 465
Carcinoid syndrome 466
Diagnostic investigations 467
Tumor localization and staging 468
Treatment 469
Prognosis 471
80 Insulinomas

472

Deﬁnition 472
Incidence 472
Clinical presentation 472
Biochemical investigations 472
Tumor localization 473
Treatment 474
Prognosis 474
81 Gastrinomas

475

Deﬁnition 475
Prevalence 475
Clinical presentation 475
Biochemical investigations 476
Treatment 477
82 Glucagonomas
Deﬁnition 478
Incidence 478
Clinical presentation 478
Biochemical investigations 479

478

xxi

xxii

DETAILED CONTENTS

Tumour localization 479
Treatment 480
83 VIPomas

481

Deﬁnition 481
Clinical presentation 481
Biochemical investigations 482
Tumor localization 482
Treatment 482
84 Somatostatinomas

483

Deﬁnition 483
Clinical features 483
Biochemical investigations 484
Tumor localization 484
Treatment 484

Part 9 Inherited endocrine syndromes and
multiple endocrine neoplasia (MEN)
85 McCune–Albright syndrome

486

Deﬁnition 486
Genetics 486
Clinical features 487
Prognosis 488
86 Neuroﬁbromatosis

489

Deﬁnition 489
NF1 490
87 Von Hippel–Lindau disease

492

Deﬁnition 492
Genetics 493
Clinical features 494
Prognosis 495
88 Carney complex

496

Deﬁnition 496
Genetics 496
Clinical presentation 496
89 Cowden syndrome
Incidence 497
Genetics 497
Clinical presentation 497

497

DETAILED CONTENTS

90 POEMS syndrome

498

Deﬁnition 498
Clinical presentation 498
Treatment 498
91 MEN type 1

499

Deﬁnition 499
Genetics 499
Clinical features 499
Management 501
Mutational analysis 501
Screening 502
92 MEN type 2

503

Deﬁnition 503
Genetics 503
Clinical features—MEN2a 504
Clinical features—MEN2b 505
Management 505
Mutational analysis 506
Screening 506
93 Inherited primary hyperparathyroidism

507

Epidemiology 507
Causes 507
HPT-JT 507
FIHP 508
94 Inherited renal calculi

509

Deﬁnition 509
Genetics 510
Management 511

Part 10 Miscellaneous endocrinology
95 Hypoglycemia

514

Deﬁnition (Whipple’s triad) 514
Epidemiology 515
Pathophysiology 516
Clinical features 517
Management 519
Postprandial reactive hypoglycemia (PRH) 520
96 Obesity
Deﬁnition 522
Epidemiology 523
Etiology 524

522

xxiii

xxiv

DETAILED CONTENTS

Pathophysiology 526
Consequences of obesity 527
Evaluation of an obese patient 528
Investigations 529
Management 530
97 Endocrinology and aging

534

Introduction 534
Fluid and electrolyte homeostasis in the elderly 535
Bone disease 537
GH and IGF-1 in the elderly 538
Gonadal function in the elderly 539
Adrenal function in the elderly 541
Thyroid disease 542
98 Endocrinology of critical illness

544

Endocrine dysfunction and AIDS 544
Cancer 549
Syndromes of ectopic hormone production 550
Liver disease 554
Renal disease 556
Endocrinology in the critically ill 558
99 Perioperative management of endocrine patients

561

Transsphenoidal surgery/craniotomy 561
Thyroidectomy 564
Parathyroidectomy 565
Pheochromocytoma 567
100 Syndromes of hormone resistance

569

Deﬁnition 569
Thyroid hormone resistance 569
Androgen resistance 569
Glucocorticoid resistance 569
ACTH resistance 570
Mineralocorticoid resistance 570
Differential diagnosis of possible manifestations of
endocrine disorders 571
101 Stress and the endocrine system

575

Deﬁnition 575
Endocrine effects of stress 576
Metabolism 576
102 Alternative or complementary therapy
and endocrinology
Introduction 577
Alternative therapy used in patients with diabetes
mellitus 578

577

DETAILED CONTENTS

Alternative therapy used in menopause 580
Alternative therapy used by patients with
osteoporosis 582
Miscellaneous 584

Part 11 Diabetes
103 Classiﬁcation and diagnosis

586

Background 586
Diagnosis 586
Classiﬁcation 587
Genetics 590
104 General management and treatment

593

Background 593
Assessment of the newly diagnosed patient 594
Dietary advice 595
Oral hypoglycemic agents 595
Insulin 599
105 Diabetic eye disease

604

Epidemiology 604
Clinical features and histological features 605
Eye screening 607
Treatment 609
Surgical treatment 610
106 Diabetic renal disease

612

Background 612
Deﬁnition 612
Epidemiology 613
Making the diagnosis 613
Pathology 614
Pathogenesis 614
Natural history 615
Treatment 616
107 Diabetic neuropathy

619

Deﬁnition 619
Pathology 619
Pathogenesis 620
Peripheral sensorimotor neuropathy 621
Autonomic neuropathy 624
108 Macrovascular disease
Epidemiology 627
Pathogenesis 628

627

xxv

xxvi

DETAILED CONTENTS

Lipid abnormalities found in patients with diabetes 629
Hypertension 632
109 Diabetic foot

636

Risk factors for foot ulcer development 637
Treatment 638
110 Diabetes and pregnancy

641

Background 641
Risks 641
Known diabetics and pregnancy 642
Gestational diabetes 644
111 Intercurrent events or disease

648

Surgery 648
Skin, connective tissue, or joint disease 649
112 Emergencies in diabetes

651

Diabetic ketoacidosis 651
Hyperosmolar, nonketotic hyperglycemia 655
Hypoglycemia 656

Part 12 Lipids and hyperlipidemia
113 Lipids and coronary heart disease

660

Physiology 660
Pathogenesis 661
Atherosclerosis 662
CHD/atherosclerosis risk factors 662
Assessment of CHD risk 663
114 Primary hyperlipidemias

669

Background 669
Polygenic hypercholesterolemia 669
Familial hypercholesterolemia (FH) 669
Clinical characterization 670
Familial defective apolipoprotein B-100 (FDB) 671
Familial hypertrigyceridemia 671
Rare genetic hypertriglyceridemias 671
Familial combined hyperlipidemia (FCHL) 672
Familial dysbetalipoproteinemia 672
Rare familial mixed dyslpidemias 673
115 Secondary hyperlipidemias
Background 674
Causes 674

674

DETAILED CONTENTS

116 Management of dyslipidemia

677

Background 677
Primary and secondary prevention 677
Drug therapy 678
Aims of treatment 684

Part 13 Laboratory endocrinology
117 Pitfalls in laboratory endocrinology

688

Introduction 688
Pre-analytical factors 689
Analytical factors 690
Post-analytical factors 691
118 Reference intervals
Introduction 693
Thyroid function 693
Adrenal and gonadal function 694
Pituitary hormones 695
Bone biochemistry 696
Plasma gastrointestinal and pancreatic hormones 696
Tumor markers 697
Urinary collections 697
